C1825 HCPCS Level II code: Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)
C1825 is the HCPCS code for “Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C1825Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)
Short description: Gen, neuro, carot sinus baro
HCPCS · United States
Medicare details
The indicators CMS publishes with C1825 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Medical/surgical supplies
- Coverage statute
- 1833(T)
- Added
- Jan 1, 2021
Where C1825 sits
- 1C codesOutpatient prospective payment system
- 2Active code C1825Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C1825 mean?
C1825 is the HCPCS code for “Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C1825?
CMS lists C1825’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C1825
All C codesC1819Surgical tissue localization and excision device (implantable)C1820Generator, neurostimulator (implantable), with rechargeable battery and charging systemC1821Interspinous process distraction device (implantable)C1822Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging systemC1823Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leadsC1824Generator, cardiac contractility modulation (implantable)C1826Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging systemC1827Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controllerC1830Powered bone marrow biopsy needleC1831Interbody cage, anterior, lateral or posterior, personalized (implantable)C1832Autograft suspension, including cell processing and application, and all system componentsC1833Monitor, cardiac, including intracardiac lead and all system components (implantable)